LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_017617.5:c.7541_7542del
NOTCH1
· NP_060087.3:p.(Pro2514ArgfsTer4)
· NM_017617.5
GRCh37: chr9:139390648 CAG>C
·
GRCh38: chr9:136496196 CAG>C
Gene:
NOTCH1
Transcript:
NM_017617.5
Final call
VUS
PM2 supporting
Variant details
Gene
NOTCH1
Transcript
NM_017617.5
Protein
NP_060087.3:p.(Pro2514ArgfsTer4)
gnomAD AF
1.1179471509116859e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: the variant is extremely rare in gnomAD v4.1, with grpmax FAF 7.64e-06 and zero homozygotes.
Final determination:
Generic ACMG/AMP 2015 fallback rules classify the variant as VUS because one supporting criterion alone satisfies none of the pathogenic, likely pathogenic, benign, or likely benign combinations.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Not met | Not met: the exon 34 frameshift ends at residue 2517 instead of 2556 and removes the PEST degron, producing prolonged NOTCH1 activation rather than a demonstrated null allele. |
PMID:25741868
PMID:29998084
pvs1_variant_assessment
|
| PS1 | N/A | Not applicable: PS1 requires a missense variant, and this is a frameshift variant. |
generic_acmg_combination_rules
|
| PS2 | Not assessed | Not assessed: no documented germline de novo finding with both maternity and paternity confirmed and no family-history information is available. |
PMID:30087429
PMID:29998084
|
| PS3 | Not assessed | Not assessed: exact-variant evidence is limited to sequencing detection, while no validated functional assay result for p.P2514Rfs*4 is available. |
PMID:30087429
PMID:29998084
PMID:25564152
PMID:19604236
|
| PS4 | Not assessed | Not assessed: 2/12 CLL patients carried the exact variant, but no matched unaffected-control cohort supports the required OR >5.0 with a confidence interval excluding 1.0. |
PMID:30087429
PMID:29998084
gnomad_v4
|
| PM1 | N/A | Not applicable: PM1 requires a missense variant, and this is a frameshift variant. |
generic_acmg_combination_rules
|
| PM2 | Met | Met at supporting strength: gnomAD v4.1 grpmax FAF is 7.64e-06, below the supplied PM2 threshold of 0.0001, with zero homozygotes. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| PM3 | Not assessed | Not assessed: no pathogenic allele, recessive inheritance, or parental/offspring phase testing establishes this variant in trans. |
PMID:30087429
PMID:29998084
|
| PM4 | N/A | Not applicable: PM4 requires a protein-length change, and this is a frameshift variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | N/A | Not applicable: PM5 requires a missense variant, and this is a frameshift variant. |
generic_acmg_combination_rules
|
| PM6 | Not assessed | Not assessed: no germline case is documented as assumed de novo without confirmed maternity and paternity. |
PMID:30087429
PMID:29998084
|
| PP1 | Not assessed | Not assessed: no affected relatives, informative meioses, or familial genotype-phenotype cosegregation data are reported. |
PMID:30087429
PMID:29998084
|
| PP2 | N/A | Not applicable: PP2 requires a missense variant, and this is a frameshift variant. |
generic_acmg_combination_rules
|
| PP3 | N/A | Not applicable: the c.7541_7542del frameshift is outside PP3's missense or intronic/synonymous/splice-region computational scope. |
|
| PP4 | Not met | Not met: CLL is genetically heterogeneous, and the available records provide no highly specific patient phenotype or family history for a single-gene disease. |
PMID:30087429
PMID:29998084
PMID:22237449
|
| PP5 | Not met | Not met: ClinVar has zero expert-panel submissions for the exact variant, and all three germline laboratory submissions classify it as uncertain significance. |
clinvar
PMID:30087429
PMID:29998084
|
| BA1 | Not met | Not met: gnomAD grpmax FAF is 7.64e-06, far below the 0.05 BA1 threshold, with no qualifying high-frequency population signal. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS1 | Not met | Not met: gnomAD v4.1 grpmax FAF is 7.64e-06, below the generic 0.01 BS1 threshold and not evidence of excess disease frequency. |
gnomad_v2
gnomad_v4
PMID:25741868
|
| BS2 | Not assessed | Not assessed: gnomAD shows zero homozygotes, but no phenotype-reviewed healthy adult individual is documented for the BS2 inheritance and penetrance requirements. |
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: sequencing confirms the exact deletion, but no validated assay demonstrates preserved NOTCH1 function or normal splicing. |
PMID:30087429
PMID:29998084
PMID:25564152
PMID:19604236
|
| BS4 | Not assessed | Not assessed: no informative affected relatives lacking the variant or other familial non-segregation evidence is documented. |
PMID:30087429
PMID:29998084
|
| BP1 | N/A | Not applicable: BP1 requires a missense variant, and this is a frameshift variant. |
generic_acmg_combination_rules
|
| BP2 | Not assessed | Not assessed: no phased pathogenic variant in cis or trans is documented for this germline case. |
PMID:30087429
PMID:29998084
|
| BP3 | N/A | Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a frameshift variant. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | N/A | Not applicable: BP4 is excluded for this frameshift, regardless of its SpliceAI max delta score of 0.007. |
|
| BP5 | Not assessed | Not assessed: the records do not establish an alternate molecular basis for disease in a case carrying the exact variant. |
PMID:30087429
PMID:29998084
|
| BP6 | Not met | Not met: no exact-variant ClinVar expert-panel submission reports benign or likely benign, while all three laboratory submissions report uncertain significance. |
clinvar
|
| BP7 | N/A | Not applicable: BP7 requires a synonymous variant, and this is a frameshift variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.